4.7 Editorial Material

Use of omalizumab to improve desensitization safety in allergen immunotherapy

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 133, Issue 3, Pages 937-U588

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2013.12.1089

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available